期刊
METABOLITES
卷 12, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/metabo12121215
关键词
sickness behaviour; phytomedicine; natural products; lipopolysaccharide; acute infections
资金
- Ministry of Education in Saudi Arabi
- [IFP2021-078]
This review summarizes the protective benefits and mechanisms of action of herbal bioactive compounds (HBACs) in reducing lipopolysaccharide (LPS)-induced sickness behavior. A total of 41 articles were reviewed, including studies conducted in mice and rats. The effects of 34 HBACs on LPS-induced changes in behavior and biochemistry were investigated.
The host's response to acute infections or tissue injury is a sophisticated and coordinated adaptive modification called sickness behaviour. Many herbs have been studied for their ability to protect animals against experimentally induced sickness behaviour. However, there is a lack of knowledge and experimental evidence on the use of herbal bioactive compounds (HBACs) in the management of sick behaviour. The goal of this review is to provide a concise summary of the protective benefits and putative mechanisms of action of phytochemicals on the reduction of lipopolysaccharide (LPS)-induced sickness behaviour. Relevant studies were gathered from the search engines Scopus, ScienceDirect, PubMed, Google Scholar, and other scientific databases (between 2000 and to date). The keywords used for the search included Lipopolysaccharide OR LPS OR Sickness behaviour OR Sickness AND Bioactive compounds OR Herbal medicine OR Herbal drug OR Natural products OR Isolated compounds. A total of 41 published articles that represented data on the effect of HBACs in LPS-induced sickness behaviour were reviewed and summarised systemically. There were 33 studies that were conducted in mice and 8 studies in rats. A total of 34 HBACs have had their effects against LPS-induced changes in behaviour and biochemistry investigated. In this review, we examined 34 herbal bioactive components that have been tested in animal models to see if they can fight LPS-induced sickness behaviour. Future research should concentrate on the efficacy, safety, and dosage needed to protect against illness behaviour in humans, because there is a critical shortage of data in this area.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据